172 related articles for article (PubMed ID: 23735574)
1. PEG length and chemical linkage controls polyacridine peptide DNA polyplex pharmacokinetics, biodistribution, metabolic stability and in vivo gene expression.
Khargharia S; Kizzire K; Ericson MD; Baumhover NJ; Rice KG
J Control Release; 2013 Sep; 170(3):325-33. PubMed ID: 23735574
[TBL] [Abstract][Full Text] [Related]
2. High-affinity PEGylated polyacridine peptide polyplexes mediate potent in vivo gene expression.
Kizzire K; Khargharia S; Rice KG
Gene Ther; 2013 Apr; 20(4):407-16. PubMed ID: 22786534
[TBL] [Abstract][Full Text] [Related]
3. Metabolically stabilized long-circulating PEGylated polyacridine peptide polyplexes mediate hydrodynamically stimulated gene expression in liver.
Fernandez CA; Baumhover NJ; Duskey JT; Khargharia S; Kizzire K; Ericson MD; Rice KG
Gene Ther; 2011 Jan; 18(1):23-37. PubMed ID: 20720577
[TBL] [Abstract][Full Text] [Related]
4. Discovery of metabolically stabilized electronegative polyacridine-PEG peptide DNA open polyplexes.
Fernandez CA; Baumhover NJ; Anderson K; Rice KG
Bioconjug Chem; 2010 Apr; 21(4):723-30. PubMed ID: 20218669
[TBL] [Abstract][Full Text] [Related]
5. Structure-Activity Relationship of PEGylated Polylysine Peptides as Scavenger Receptor Inhibitors for Non-Viral Gene Delivery.
Baumhover NJ; Duskey JT; Khargharia S; White CW; Crowley ST; Allen RJ; Rice KG
Mol Pharm; 2015 Dec; 12(12):4321-8. PubMed ID: 26485572
[TBL] [Abstract][Full Text] [Related]
6. Efficient expression of stabilized mRNA PEG-peptide polyplexes in liver.
Crowley ST; Poliskey JA; Baumhover NJ; Rice KG
Gene Ther; 2015 Dec; 22(12):993-9. PubMed ID: 26125604
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro testing of new potent polyacridine-melittin gene delivery peptides.
Baumhover NJ; Anderson K; Fernandez CA; Rice KG
Bioconjug Chem; 2010 Jan; 21(1):74-83. PubMed ID: 19968269
[TBL] [Abstract][Full Text] [Related]
8. The uptake mechanism of PEGylated DNA polyplexes by the liver influences gene expression.
Khargharia S; Baumhover NJ; Crowley ST; Duskey J; Rice KG
Gene Ther; 2014 Dec; 21(12):1021-8. PubMed ID: 25253445
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the transfection property of a peptide ligand for the fibroblast growth factor receptor as part of PEGylated polyethylenimine polyplex.
Rao GA; Tsai R; Roura D; Hughes JA
J Drug Target; 2008 Jan; 16(1):79-89. PubMed ID: 18172824
[TBL] [Abstract][Full Text] [Related]
10. PEGylated poly(2-(dimethylamino) ethyl methacrylate)/DNA polyplex micelles decorated with phage-displayed TGN peptide for brain-targeted gene delivery.
Qian Y; Zha Y; Feng B; Pang Z; Zhang B; Sun X; Ren J; Zhang C; Shao X; Zhang Q; Jiang X
Biomaterials; 2013 Mar; 34(8):2117-29. PubMed ID: 23245924
[TBL] [Abstract][Full Text] [Related]
11. Synthetic PEGylated glycoproteins and their utility in gene delivery.
Chen CP; Kim JS; Liu D; Rettig GR; McAnuff MA; Martin ME; Rice KG
Bioconjug Chem; 2007; 18(2):371-8. PubMed ID: 17373767
[TBL] [Abstract][Full Text] [Related]
12. Zwitterionic Nanocarrier Surface Chemistry Improves siRNA Tumor Delivery and Silencing Activity Relative to Polyethylene Glycol.
Jackson MA; Werfel TA; Curvino EJ; Yu F; Kavanaugh TE; Sarett SM; Dockery MD; Kilchrist KV; Jackson AN; Giorgio TD; Duvall CL
ACS Nano; 2017 Jun; 11(6):5680-5696. PubMed ID: 28548843
[TBL] [Abstract][Full Text] [Related]
13. Combinatorial optimization of PEG architecture and hydrophobic content improves ternary siRNA polyplex stability, pharmacokinetics, and potency in vivo.
Werfel TA; Jackson MA; Kavanaugh TE; Kirkbride KC; Miteva M; Giorgio TD; Duvall C
J Control Release; 2017 Jun; 255():12-26. PubMed ID: 28366646
[TBL] [Abstract][Full Text] [Related]
14. PEGylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice.
Merdan T; Kunath K; Petersen H; Bakowsky U; Voigt KH; Kopecek J; Kissel T
Bioconjug Chem; 2005; 16(4):785-92. PubMed ID: 16029019
[TBL] [Abstract][Full Text] [Related]
15. PEGylated polyplex with optimized PEG shielding enhances gene introduction in lungs by minimizing inflammatory responses.
Uchida S; Itaka K; Chen Q; Osada K; Ishii T; Shibata MA; Harada-Shiba M; Kataoka K
Mol Ther; 2012 Jun; 20(6):1196-203. PubMed ID: 22334020
[TBL] [Abstract][Full Text] [Related]
16. Decationized polyplexes as stable and safe carrier systems for improved biodistribution in systemic gene therapy.
Novo L; Rizzo LY; Golombek SK; Dakwar GR; Lou B; Remaut K; Mastrobattista E; van Nostrum CF; Jahnen-Dechent W; Kiessling F; Braeckmans K; Lammers T; Hennink WE
J Control Release; 2014 Dec; 195():162-175. PubMed ID: 25204289
[TBL] [Abstract][Full Text] [Related]
17. In vivo gene transfer using sulfhydryl cross-linked PEG-peptide/glycopeptide DNA co-condensates.
Kwok KY; Park Y; Yang Y; McKenzie DL; Liu Y; Rice KG
J Pharm Sci; 2003 Jun; 92(6):1174-85. PubMed ID: 12761807
[TBL] [Abstract][Full Text] [Related]
18. DC3-decorated polyplexes for targeted gene delivery into dendritic cells.
Golani-Armon A; Golan M; Shamay Y; Raviv L; David A
Bioconjug Chem; 2015 Feb; 26(2):213-24. PubMed ID: 25560976
[TBL] [Abstract][Full Text] [Related]
19. Peptide Sequence-Dependent Gene Expression of PEGylated Peptide/DNA Complexes.
Ueno M; Yamauchi S; Kumekawa D; Yamasaki Y
Mol Pharm; 2019 Jul; 16(7):3072-3082. PubMed ID: 31173498
[TBL] [Abstract][Full Text] [Related]
20. Polyplex micelles from triblock copolymers composed of tandemly aligned segments with biocompatible, endosomal escaping, and DNA-condensing functions for systemic gene delivery to pancreatic tumor tissue.
Miyata K; Oba M; Kano MR; Fukushima S; Vachutinsky Y; Han M; Koyama H; Miyazono K; Nishiyama N; Kataoka K
Pharm Res; 2008 Dec; 25(12):2924-36. PubMed ID: 18781378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
